Despite finalizing the last of its rules implementing the Food Safety Modernization Act, the Food and Drug Administration will keep taking input from the public on the sweeping regulations, the agency’s new deputy commissioner for foods and veterinary medicine said in a question-and-answer session posted on its website.
“There’s no guarantee that we dotted all the ‘I’s and crossed all the ‘T’s exactly right as we finalized these regulations, despite all of the feedback through stakeholder engagement sessions and the public comments that we received,” Stephen Ostroff said in the June 3 posting.
Ostroff is no stranger to anybody who has been following agriculture policy. Before his new gig, Ostroff served in several posts at the FDA, including as acting commissioner of the entire agency from April 2015 until Congress confirmed its current head, Robert Califf, in February 2016. Ostroff is taking on oversight of food and veterinary medicine from Michael Taylor, who became the program’s first deputy director in 2010.
Ostroff is coming on just after the agency finalized May 26 the last of seven major rules implementing the comprehensive food safety law enacted in 2011. The final rule addresses intentional adulteration of the food supply. Analysts say stakeholders can expect the FDA to issue more guidance clarifying the rules in the coming years.
Ostroff also touched on how the FDA will handle foodborne illness outbreaks, saying he would step up monitoring FSMA compliance and employing new technologies to trace contamination.
“One of the best tools we’ll be using more frequently is whole genome sequencing, a scientific tool that is something of a game changer in how rapidly it enables us to identify an outbreak and find the source,” Ostroff said.
Stopping the spread of antibiotic-resistant bacteria is also a top priority he said.
“We recently expanded sales data collection to require that sponsors of antimicrobial medications provide estimates of their sales data broken down by species of food-producing animals, in addition to overall sales,” Ostroff said.
In March, the FDA clarified how it planned to roll out new guidance aimed at reducing the over-the-counter use of antibiotics important to human health in livestock.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)